Alloy vs Emerge Weight Loss
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Alloy
Best for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directoryStarting at $80/mo
Emerge Weight Loss
Best for patients committed to tirzepatide as their drug of choiceStarting at $299/mo
Side-by-Side Comparison
| Feature | Alloy | Emerge Weight Loss |
|---|---|---|
| Overall Score | 7.4/10 | ✓7.6/10 |
| Starting Price | ✓$80/mo | $299/mo |
| Editorial Rating | 3.7 ★ /5 | ✓3.8 ★ /5 |
| Features | ✓8 features | 4 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Alloy
Pros
- ✓Broadest GLP-1 formulary in our catalog: brand Wegovy + brand Zepbound + oral Wegovy + compounded semaglutide + compounded tirzepatide + compounded liraglutide
- ✓All consulting doctors are certified by The Menopause Society — only ~1,000 such certified practitioners exist among ~20,000 OB-GYNs in the US
- ✓Brand-name Wegovy starting at $199/mo and compounded liraglutide starting at $80/mo cover both ends of the price/access spectrum
- ✓STARTGLP1 promo code knocks $50 off the first month per the public site
Cons
- ✗Not available in Louisiana or Mississippi (verified) — readers in those two states should be routed elsewhere
- ✗Initial consultation is $49 and is separate from medication cost — readers should know there's a non-refundable upfront fee
- ✗Menopause-specialty framing — best fit for women in menopause/perimenopause, not the right product for men or younger women whose primary need is weight loss
Emerge Weight Loss
Pros
- ✓Tirzepatide-focused (largest effect-size compounded GLP-1)
- ✓Wide dose range available
- ✓Physician-supervised telemedicine model
Cons
- ✗No semaglutide option — limits flexibility if tirzepatide tolerability is poor
- ✗Less brand recognition than Henry Meds, Mochi, or SkinnyRx
Our Verdict
Emerge Weight Loss edges out Alloy with a higher overall score of 7.6/10 and is particularly strong for patients committed to tirzepatide as their drug of choice. Alloy remains a solid alternative, especially if you're looking for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directory.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.